Tumours and tremors: how PTEN regulation underlies both

R H Kim1, T W Mak

  • 1Campbell Family Institute for Breast Cancer Research, 620 University Avenue, Toronto, Ontario M5G 2C1, Canada.

British Journal of Cancer
|February 24, 2006
PubMed

Insights

Tumour suppressor PTEN (phosphatase and tensin homolog deleted on chromosome 10) mutations are linked to cancer. Recent research explores PTEN regulation

Area of Science:

  • Oncology
  • Neuroscience
  • Molecular Biology

Background:

  • PTEN (phosphatase and tensin homolog deleted on chromosome 10) is a critical tumour suppressor.
  • PTEN mutations are prevalent in various human cancers.
  • Emerging evidence suggests PTEN dysregulation in neurodegenerative diseases like Parkinson's disease.

Purpose of the Study:

  • To review recent advancements in understanding PTEN regulation.
  • To explore the dual role of PTEN in both cancer and neurodegenerative disease pathogenesis.
  • To highlight potential therapeutic implications of PTEN modulation.

Main Methods:

  • Literature review of recent studies on PTEN.
  • Analysis of molecular mechanisms underlying PTEN regulation.
  • Synthesis of findings linking PTEN to cancer and neurodegeneration.

Main Results:

  • PTEN plays a complex role in cellular processes beyond tumour suppression.
  • Dysregulation of PTEN pathways contributes to the development of neurodegenerative conditions.
  • Understanding PTEN regulation offers insights into novel therapeutic strategies.

Conclusions:

  • PTEN is a key player in both oncogenesis and neurodegeneration.
  • Targeting PTEN pathways may offer a unified approach for treating diverse diseases.
  • Further research into PTEN regulation is crucial for clinical applications.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...